Midiana

Drospirenone/Ethinylestradiol, the active ingredient in Midiana, is a combined oral contraceptive presented as a tablet for oral use. It prevents pregnancy and helps regulate menstrual cycles in women of reproductive age by suppressing ovulation, thickening cervical mucus, and modifying the endometrial lining for reliable cycle control. The formulation complies with EU standards and is intended for daily oral administration under medical supervision.

GNH USA supplies Midiana as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality and regulatory compliance across global markets.

Midiana, a combined oral contraceptive, is indicated for hormonal contraception and menstrual cycle regulation.

Contraception: provides reliable prevention of pregnancy in women of reproductive age. Menstrual cycle regulation: helps achieve more predictable and lighter menstrual bleeding. Management of hormone‑related menstrual disorders: reduces dysmenorrhea and improves cycle regularity.

Midiana may cause a range of adverse reactions, which are categorized by frequency and severity.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Headache: tension‑type or migraine‑like pain. - Breast tenderness: swelling or discomfort. - Spotting or breakthrough bleeding: irregular light bleeding. - Weight gain: modest increase in body weight. - Mood changes: irritability or emotional fluctuations.

Serious or Rare Side Effects: - Deep vein thrombosis: blood clot formation in veins. - Pulmonary embolism: clot migration to lung vessels. - Stroke: cerebrovascular accident due to clot or hemorrhage. - Myocardial infarction: heart attack from coronary blockage. - Severe allergic reaction: anaphylaxis, rash, or swelling. - Liver disorders: jaundice, hepatitis, or abnormal liver enzymes.

Before prescribing Midiana, clinicians should evaluate individual risk factors and contraindications.

Pregnancy contraindication: do not use in women who are or may become pregnant. Smoking restriction: avoid in women over 35 who smoke. Thromboembolic history: contraindicated in patients with prior clotting events. Hypertension: monitor blood pressure and avoid if uncontrolled. Liver disease: use with caution in hepatic impairment. Store at ambient temperature: keep below 25 °C in the original packaging, protect from moisture and direct sunlight.

Midiana can interact with several medicines, altering its effectiveness or safety profile.

Major Interactions (Avoid): - Rifampin: strong CYP3A4 inducer that reduces contraceptive efficacy. - St. John’s wort: herbal inducer that may diminish hormone levels. - Certain anticonvulsants (e.g., carbamazepine, phenytoin): decrease plasma concentrations.

Moderate Interactions (Monitor Closely): - Antifungal agents (e.g., ketoconazole, itraconazole): may increase hormone exposure. - SSRIs (e.g., fluoxetine, sertraline): potential for modest pharmacokinetic changes. - Antihypertensives (e.g., ACE inhibitors): monitor blood pressure control. - Antidiabetic drugs: watch for altered glucose control. - Herbal supplements (e.g., ginseng): possible interaction with metabolism.